birth changes dramatically old age vaccine effective healthy adults not work beginning end life example pharmaceutical giant glaxosmithkline developed malaria vaccine cost $ 2 billion shown protect 30 50 percent adults 19 percent babies dowling says provide protection infants age months highest risk dying malaria 2016 dowling levy found white blood cells infants not mount strong response adjuvant similar malaria vaccine suggesting need identify adjuvants greater activity early life levy dowling beginning develop test adjuvants combined covid-19 vaccine candidates levy says menu adjuvants portion team testing flu vaccine work includes buy shelf homegrown based screening studies small molecules supported u.s.